Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover

Status Recruiting

Clinical Trial Summary

The goal of this randomised trial is to learn about the role of AI in clinical coding practice. The main question it aims to answer is: Can the AI-based CAC system reduce the burden of clinical coding and also improve the quality of such coding? Participants will be asked to code clinical texts both while they use our CAC system and while they do not.

Clinical Trial Description

Once participants are recruited, they are randomly allocated to 2 groups without allocation concealment. Allocation concealment will not be relevant for clinical coders since it is known whether a participant is assisted or not, and we will not develop a placebo coding assistant. We will, however, conceal the allocation of subjects for the analyses. In total, participants will code 20 clinical notes, where each note belongs to a single patient. The participants are asked to complete the experiment in 1 sitting without interruptions, and they cannot revisit or go back to previous notes. In the event that participants are interrupted, they are asked to exit the experiment, and any incomplete records are discarded as invalid. The user study process can be summarized in the following steps: 1. Study participants are randomly allocated to group 1 and group 2. 2. To prepare participants for the experiment, a short video tutorial is played after the consent form is signed and right before the clinical coding task commences. 3. In period 1 with 10 clinical notes, group 1 uses the control interface, while group 2 uses the intervention interface. 4. Data are logged in the background using button presses (eg. time, assigned codes, and comments). 5. Then, there is an immediate crossover to period 2 for the last 10 clinical notes. 6. Data continue to be logged in the background using button presses. 7. At the end, participants in both groups will complete the system usability scale. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06286865
Study type	Interventional
Source	University Hospital of North Norway
Contact	Taridzo F Chomutare, PhD
Phone	+4747680032
Email	taridzo.chomutare@ehealthresearch.no
Status	Recruiting
Phase	N/A
Start date	October 20, 2023
Completion date	April 2024

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT02541357` - Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery	N/A
Active, not recruiting	`NCT02358122` - Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh	N/A
Active, not recruiting	`NCT02442115` - Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
Enrolling by invitation	`NCT00943345` - Validation of New Tests for Gastrointestinal (GI) Permeability	Phase 0
Completed	`NCT00612404` - Symptoms and Endoscopic Results in Consideration of Pretreatment	N/A
Completed	`NCT01127711` - Cohort of Swedish Men	N/A
Recruiting	`NCT05712525` - Gut Recovery In Patients Following Surgery
Recruiting	`NCT06094153` - Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function	N/A
Recruiting	`NCT05322486` - Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Completed	`NCT02486146` - GI Biorepository of Tissue and Bodily Fluids	N/A
Completed	`NCT01816607` - Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
Completed	`NCT00247715` - Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)	N/A
Completed	`NCT00035334` - Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis	Phase 2/Phase 3
Active, not recruiting	`NCT01037049` - Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks	Phase 2
Completed	`NCT03725813` - Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit	N/A
Recruiting	`NCT05640401` - Holographic Screens as a Replacement of Monitors During GI Endoscopies	N/A
Completed	`NCT02865564` - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics	N/A
Completed	`NCT02651857` - Exploratory Study of Upper and Lower Endoscopic Fuse System	N/A
Active, not recruiting	`NCT01984034` - Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines	N/A
Completed	`NCT01463319` - Warm Water and Unsedated Colonoscopy	Phase 0

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial — ClinCode

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms